356 related articles for article (PubMed ID: 11104833)
1. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
[TBL] [Abstract][Full Text] [Related]
2. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
[TBL] [Abstract][Full Text] [Related]
3. Characterization of bradykinin B(2) receptor antagonists in human and rat urinary bladder.
Meini S; Patacchini R; Giuliani S; Lazzeri M; Turini D; Maggi CA; Lecci A
Eur J Pharmacol; 2000 Jan; 388(2):177-82. PubMed ID: 10666510
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.
Asano M; Hatori C; Sawai H; Johki S; Inamura N; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Mizutani T; Oku T; Nakahara K
Br J Pharmacol; 1998 Jun; 124(3):441-6. PubMed ID: 9647466
[TBL] [Abstract][Full Text] [Related]
5. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
[TBL] [Abstract][Full Text] [Related]
6. Antagonistic effects of novel non-peptide chlorobenzhydryl piperazine compounds on contractile response to bradykinin in the guinea-pig ileum.
Kam YL; Ro JY; Kim HJ; Choo HY
Eur J Pharmacol; 2005 Oct; 523(1-3):143-50. PubMed ID: 16226247
[TBL] [Abstract][Full Text] [Related]
7. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
[TBL] [Abstract][Full Text] [Related]
8. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
[TBL] [Abstract][Full Text] [Related]
9. Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657).
Gobeil F; Montagne M; Inamura N; Regoli D
Immunopharmacology; 1999 Sep; 43(2-3):179-85. PubMed ID: 10596851
[TBL] [Abstract][Full Text] [Related]
10. The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657.
Asano M; Inamura N; Hatori C; Sawai H; Fujiwara T; Katayama A; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Nakahara K; Oku T; Okuhara M
Br J Pharmacol; 1997 Feb; 120(4):617-24. PubMed ID: 9051299
[TBL] [Abstract][Full Text] [Related]
11. Characterization of FR173657, a novel nonpeptide B2 antagonist: in vitro and in vivo studies.
Inamura N; Asano M; Kayakiri H; Hatori C; Oku T; Nakahara K
Can J Physiol Pharmacol; 1997 Jun; 75(6):622-8. PubMed ID: 9276139
[TBL] [Abstract][Full Text] [Related]
12. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
Meini S; Lecci A; Maggi CA
Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.
Paquet JL; Luccarini JM; Fouchet C; Defrêne E; Loillier B; Robert C; Bélichard P; Cremers B; Pruneau D
Br J Pharmacol; 1999 Mar; 126(5):1083-90. PubMed ID: 10204994
[TBL] [Abstract][Full Text] [Related]
14. 5-hydroxytryptamine release from skin mast cells in vivo induced by peptide but not by nonpeptide ligands for bradykinin receptors.
Griesbacher T; Rainer I
Immunopharmacology; 1999 Sep; 43(2-3):195-201. PubMed ID: 10596853
[TBL] [Abstract][Full Text] [Related]
15. Interaction of linear and cyclic peptide antagonists at the human B(2) kinin receptor.
Cucchi P; Meini S; Quartara L; Giolitti A; Zappitelli S; Rotondaro L; Maggi CA
Peptides; 2002 Aug; 23(8):1457-63. PubMed ID: 12182947
[TBL] [Abstract][Full Text] [Related]
16. Mouse paw edema induced by a novel bradykinin agonist and its inhibition by B2-antagonists.
Ueno A; Naraba H; Oh-ishi S
Jpn J Pharmacol; 1998 Sep; 78(1):109-11. PubMed ID: 9804073
[TBL] [Abstract][Full Text] [Related]
17. Site-directed mutagenesis at the human B2 receptor and molecular modelling to define the pharmacophore of non-peptide bradykinin receptor antagonists.
Meini S; Cucchi P; Bellucci F; Catalani C; Faiella A; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Biochem Pharmacol; 2004 Feb; 67(4):601-9. PubMed ID: 14757160
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin B2 receptors and coupling mechanisms in the smooth muscle of the guinea-pig taenia caeci.
Field JL; Butt SK; Morton IK; Hall JM
Br J Pharmacol; 1994 Oct; 113(2):607-13. PubMed ID: 7834214
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activity of analogues of the kinin B2 receptor antagonist MEN1 1270.
Meini S; Lecci A; Carini F; Tramontana M; Giuliani S; Maggi CA; Ricci R; Fabbri G; Anichini B; Harmat N; Rizzi A; Camarda V; Regoli D; Quartara L
Can J Physiol Pharmacol; 2002 Apr; 80(4):293-302. PubMed ID: 12025964
[TBL] [Abstract][Full Text] [Related]
20. In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist.
Drube S; Liebmann C
Br J Pharmacol; 2000 Dec; 131(8):1553-60. PubMed ID: 11139431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
